France yet today you work for a foreign multinational within France. Can you speak to the differences in culture and what the transition has been like?…
In Conversation
Interview with Michel Hannoun, President, ACIP – Association des Cadres de l’Industrie Pharmaceutique

The French President declared that he intended to make France the most welcoming and attractive place for the healthcare industry. Do you think this is possible?…
Interview with André Syrota, Director – General, INSERM – l'Institut National de la Santé et de la Recherche Médicale

After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment…
What are the main tasks of the LEEM? The LEEM is the only professional organization representing the pharmaceutical industry in France. It includes almost all companies…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within…
FPS is a hundred year old organization with roots in the beginning of the last century representing today SME suppliers to the health industries. Given the…
Interview with Guillaume Bouchara, General Secretary, AGIPHARM – Association des Groupes Internationaux pour la Pharmacie de Recherche
US pharmaceutical companies have long been in the French market but in your experience how do you feel they have integrated the differences in culture? Is…
Generic drugs were a very late arrival for the French market in comparison with other European markets and healthcare systems on a par with the French…
Roche, once a true pharmaceutical company, is now recognized by its capacity to create a unique business model that allowed to become the world’s largest biotech…
Interview with Jean-Pierre Cassan, Honrary President of the LEEM, LEEM – Les Enterprises du Medicament

Throughout your prolific career in the pharmaceutical industry, what would you describe have been the major changes in the French pharmaceutical market and to what extent…
Having experienced many years at big pharmaceutical companies, you recently moved into the booming biotech sector by joining Biogen Idec in 2007. What made you make…